Institutions / Affinity Asset Advisors, LLC / Holdings
Back to Affinity Asset Advisors, LLC

Affinity Asset Advisors, LLC

All holdings · as of Dec 31, 2025

86 positions

CompanyClassValue ↓Shares% of portfolio
Apogee Therapeutics, Inc.—$93.21M1,234,9266.7%
INSMED INC—$78.32M450,0005.6%
ABIVAX SA—$68.10M505,0004.9%
Ventyx Biosciences, Inc.—$58.56M6,484,5584.2%
Xenon Pharmaceuticals Inc.—$56.02M1,250,0004.0%
Praxis Precision Medicines, Inc.—$54.53M185,0003.9%
Cytokinetics Inc—$50.83M800,0003.7%
SPYRE THERAPEUTICS, INC.—$46.93M1,432,5913.4%
WAVE LIFE SCIENCES LTD—$45.90M2,700,0003.3%
TEVA PHARMACEUTICAL INDUSTRIES LTDTEVAADR$43.69M1,400,0003.1%
Roivant Sciences Ltd.—$36.89M1,700,0002.7%
Arcellx, Inc.—$34.15M523,7252.5%
Nuvalent, Inc.—$32.45M322,6332.3%
Lexeo Therapeutics, Inc.—$31.78M3,200,0002.3%
Alkermes plc.—$27.98M1,000,0002.0%
Forte Biosciences, Inc.—$26.98M989,4901.9%
Trevi Therapeutics, Inc.—$26.92M2,150,1721.9%
MINERALYS THERAPEUTICS INCMLYSCommon Stock$26.49M730,0001.9%
BridgeBio Pharma, Inc.—$24.48M320,0001.8%
Oruka Therapeutics, Inc.—$24.32M802,3421.7%
Terns Pharmaceuticals, Inc.—$22.22M550,0001.6%
AnaptysBio, Inc.—$21.56M444,6921.5%
Cullinan Therapeutics, Inc.—$20.00M1,932,1061.4%
OMEROS CORP—$19.38M6,525,0001.4%
Avalo Therapeutics, Inc.—$19.09M1,051,0541.4%
Nurix Therapeutics, Inc.—$18.36M967,6201.3%
Taysha Gene Therapies, Inc.TSHACommon Stock$18.15M3,300,0001.3%
MADRIGAL PHARMACEUTICALS, INC.—$18.13M31,1311.3%
Savara IncSVRACommon Stock$16.87M2,797,1531.2%
PROTAGONIST THERAPEUTICS INC—$15.03M172,1251.1%
CENTESSA PHARMACEUTICALS PLC—$15.02M600,5521.1%
ESTABLISHMENT LABS HOLDINGS INC.—$14.58M200,0001.0%
Erasca, Inc.ERASCommon Stock$14.51M3,900,0001.0%
Vera Therapeutics, Inc.—$12.66M250,0000.9%
Cogent Biosciences, Inc.—$12.43M350,0000.9%
Ovid Therapeutics Inc.—$11.65M7,150,0000.8%
Travere Therapeutics, Inc.—$11.46M300,0000.8%
JADE BIOSCIENCES, INC.—$11.03M714,9560.8%
TRAVERE THERAPEUTICS INC—$9.99M7,000,0000.7%
NEWAMSTERDAM PHARMA COMPANY—$9.65M275,0000.7%
Celldex Therapeutics, Inc.—$9.51M350,0000.7%
Zura Bio Limited—$9.50M1,813,6710.7%
Tango Therapeutics, Inc.—$8.86M1,000,0000.6%
Sutro Biopharma, Inc.—$8.66M748,3820.6%
Revolution Medicines, Inc.—$7.96M100,0000.6%
MBX Biosciences, Inc.MBXCommon Stock$7.88M250,0000.6%
Viridian Therapeutics, Inc.—$7.78M250,0000.6%
Arcus Biosciences, Inc.—$7.15M300,0000.5%
Sagimet Biosciences Inc.SGMTCommon Stock$6.80M1,148,2450.5%
Karyopharm Therapeutics Inc.—$6.55M889,5750.5%
← PrevPage 1 of 2Next →